A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Regenera Pharma Ltd
INC Research
Information provided by (Responsible Party):
Regenera Pharma Ltd
ClinicalTrials.gov Identifier:
First received: January 17, 2012
Last updated: June 14, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)